Moderna

Open: 90.41 Close: 88.37 Change: -2.04

The stock market through the eyes of an AI: Moderna.

This document will help you to evaluate Moderna without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Moderna are: Moderna, company, vaccine, age, year, messenger, RNA, and the …

Concept Map

Semantic Network

Stock Summary

Moderna, Inc. discovers, develops, and commercializes messenger RNA therapeutics and vaccines. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV.

Today's Summary

Covid-19 vaccine maker Moderna said 2023 product sales hit $6.7 billion, above the companys guidance, but down 60% from 2022. Moderna believes messenger RNA, or mRNA, is the “software of life”

Today's News

Moderna Therapeutics is a biotechnology company that focuses on the development of messenger RNA therapeutics and vaccines. Moderna through its mRNA therapeutics platform develops and produces human proteins, antibodies, and novel proteins, which help in preventing, treating, and curing diseases. Covid-19 vaccine maker Moderna said 2023 product sales hit $6.7 billion, above the companys guidance, but down more than 60% from 2022. Moderna has worked with former law enforcement and public health officials to confront the “root cause of vaccine hesitancy” by rapidly identifying and “shutting down misinformation” Internal files show high-profile vaccine critics were closely monitored. Moderna has closely monitored Russell Brands criticism of the drug industry. Brand has been a repeated name in the Moderna misinformation files. Moderna has raised a total funding of  $2.78B  over 17 funding rounds. Moderna serves in the B2B space in the Life Sciences market segments. The primary business model of Moderna is : Life Sciences. Moderna is a company that specializes in textile services, operating within the textile industry. In January 2024, Moderna was acquired by Elis. Moderna Biotechnology Research Cambridge, Massachusetts, is a biotechnology company that focuses on the development of messenger RNA medicines. Moderna believes messenger RNA, or mRNA, is the “software of life” Study Finds Moderna Vaccine Reduced Symptomatic COVID-19 In Young Adults - Texas A&M Today. Moderna (MRNA) gained but lagged the market today. People who are not moderately or severely immunocompromised: Recommended COVID-19 vaccination schedule. People who transition from age 4 years to age 5 years during the initial vaccination series: Moderna series. People ages 12 years and older who are immunocompromised have the option to receive 1 additional dose of updated (2023–2024 Formula) Moderna COVID-19 Vaccine for children ages 5–11 years, 0.25 mL/25ug. Moderna, Inc. (MRNA) stock price, news, quote & history - yahoo finance. markets closed S&P 500 5,005.57 -24.16 (-24.57) Dow 30 38,627.99 -145.13 (-0.37%) Nasdaq 15,77565 -130.52 (-0.82%) Russell 2000 2,032 -28 -5454 convent................TrumpEva478 RebellParts distinguishingPortdimension Gunbett improves fires

Stock Profile

"Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts."

Keywords

The game is changing. There is a new strategy to evaluate Moderna fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Moderna are: Moderna, company, vaccine, age, year, messenger, RNA, and the most common words in the summary are: moderna, vaccine, dose, covid19, job, update, week, . One of the sentences in the summary was: Covid-19 vaccine maker Moderna said 2023 product sales hit $6.7 billion, above the companys guidance, but down 60% from 2022. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #moderna #vaccine #dose #covid19 #job #update #week.